ABPI response to human medicines regulations changes

Following a consultation, the Government has today announced changes to the Human Medicines Regulations, which will support the rollout of any COVID-19 vaccine.  

In response, Dr Sheuli Porkess, Director of Research, Medical and Innovation at the ABPI said: 

“Companies have a huge sense of responsibility and urgency to create a safe and effective vaccine for COVID-19.

“When there is a breakthrough, the public can be confident it will have been through the most rigorous safety procedures and extensive trials in thousands of people.

“Given the scale of the issue, it’s important that the Government prepares in the best way possible so that any vaccine developed can reach patients when it is ready, and we are committed to working together to get this right.”